Dysmenorrhea Treatment Market - Overview:
Dysmenorrhea refers to the painful menstruation
women experience during their monthly discharging periods. While it is normal for women to have mild
abdominal cramps on the initial days of their menstruation, about 30% of women
experience severe pain along with headaches and nausea that could be termed as
Dysmenorrhea. Over the past decade, the prevalence of Dysmenorrhea is observed
to be growing. Reasons could be environmental changes, change in diet, and lack
of nutritious diet, etc.
However, the cause acting as the driving force to
prevail these conditions is changing and unhealthy lifestyle. Today’s working
women have to cope-up with physical as well as mental stress encountered at
both the fronts – personal (family) and workplace. Growing awareness among
women towards the fact that Dysmenorrhea can now be treated and the
availability and accessibility of treatments are encouraging the increasing
number of women to avail the advantages of these treatments. Resultantly,
Dysmenorrhea market is growing pervasively, becoming a lucrative space.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/727
Acknowledging the exponential growth the market
perceives currently; Market Research Future (MRFR), in its recently published
market forecast asserts that the global Dysmenorrhea Treatment market will
reach USD 8.40 Bn. by 2023, registering a striking CAGR of 12.28% throughout
the forecast period (2017 – 2023). In 2016, the market had valued at USD 5.68
Bn.
The technological advancements transpired in the
field of medical science are offering extraordinary relief and benefitting
results, proving to be a boon to the patients, improving their quality of life.
Thus, provide impetus to the market growth of Dysmenorrhea Treatments. Other factors fostering the market growth
include increasing cases of rheumatic diseases and growing awareness among the
patients towards the availability of effective treatments for FM. Rising geriatric
population, coupled with the unmet medical needs are fostering the market
growth of Dysmenorrhea treatments.
On the other hand, unmet medical needs due to the
lack of infrastructure and technical competencies ending in complicating
diagnosis processes are some of the key factor impeding the market growth
especially in the middle & low-income countries. Nevertheless, developing technologies are
likely to present new techniques to treat the condition effectively, which will
further increase the market growth during the assessment period.
Global Dysmenorrhea Treatment Market - Competitive Landscape:
The
competitive market for Dysmenorrhea Treatment is fragmented with many large and
small players operating in the market. Market players incorporate acquisition,
collaboration, expansion, technology launch and strategic partnership. These
players substantially invest in R&D and clinical trials to develop
effective drugs.
To
help accelerate pharmaceutical innovations and to gain a better understanding
of the conditions, these pharma companies collaborate with academia and the
biotech industry partners who can contribute cutting-edge technologies and
specialized knowledge.
These
collaborations are one of the innovation strategies of market players.
Companies can leverage the latest scientific knowledge and translate it into
innovative medicines through partnering. These partnerships can kindle the
innovative impulses that advance medicine and benefit patients as well as
partners.
Dysmenorrhea Treatment Market - Segmentations:
MRFR has segmented the report into three key
dynamics for an easy grasp and enhanced understanding:-
By Type : Primary and Secondary (Adenomyosis,
Endometriosis, Uterine myomas, Cervical stenosis, Endometrial polyps, and
Obstructive malformations of genital tract.).
By Treatment :Non-Steroidal Anti-Inflammatory
Drugs (Nsaids), Hormonal, and Combined Oral Contraceptive among others.
By End-User :Hospitals,
Clinics, Diagnostic Centers, and Pharmaceutical Companies
among Others.
By Regions :
North America, Europe, APAC and Rest of the World.
Global Dysmenorrhea Treatment
Market - Regional Analysis
Globally North America leads the
Dysmenorrhea Treatment market with the significant market share. The Market is
expected to grow phenomenally from 2017 to 2023. Attributing to the favorable
reimbursement scenario and higher expenditure on healthcare the market is
expected to perceive a healthy growth.
The factor contributing to the
market growth include increasing prevalence of issues and disorders associated
with women’s reproductive system fuelled by the changing lifestyle and growing
awareness towards the availability of the treatments. The US, backed by the
technological advances and availability of funding for the development of new
therapeutics and treatment accounts for the major contributor to the market
growth.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/dysmenorrhea-treatment-market-727
Europe emerging as a lucrative
market for Dysmenorrhea Treatment will expand registering a phenomenal
CAGR. The resurging economy in the
region is expected to foster the regional market growth, increasing per capita
healthcare expenditures. The financial support provided by private and
governments bodies for R&D activities and new improved reimbursement
policies in healthcare will fuel the Dysmenorrhea Treatment market in Europe.
Industry/Innovation/ Related News:
January 04, 2018 –Pfizer
Inc. (US) a pharmaceutical conglomerate announced the partnership with
23andMe (US), a privately held personal genomics and biotechnology companyto aid
understanding of depression, dysmenorrhea and the genetic heterogeneity of
lupus and inflammatory bowel disease. Pfizer believes that such collaborations
will help it to potentially usher in a new era of patient care defined by
targeted research methods and ultimately better patient outcomes.
No comments:
Post a Comment